Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.61
Mar. 16, 2026 16:00:01- Change 0.0179 (3.02723%)
- Volume 371,950
- Today's Open 0.6
- Previous Close 0.5913
- Today's High 0.6178
- Today's Low 0.5851
- 52 Week High 1.993
- 52 Week Low 0.281